No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Dan Beuerlein Appointed Chief Development Officer at Agape Care

Editor: What To Know

  • In just two years at BlueSprig, Beuerlein helped the company grow from a start-up with a few clinics in Texas to one of the largest national providers of behavioral therapy for children with autism through a network of 110 clinics in 13 states.
  • “Dan is a seasoned mergers and acquistions professional and will be counted on to help us accelerate our growth strategy by executing on key acquisitions in Georgia, North Carolina, South Carolina and Tennessee,” said Troy Yarbrough, chief executive officer of Agape Care.
  • In addition to his time at BlueSprig, Beuerlein also served as the chief development officer and executive vice president of operations at Vivere Health, a leading equity partner and fertility management company.

Dan Beuerlein has been appointed Chief Development Officer at Agape Care. The news was announced today.

Dan Beuerlein will spearhead Agape Care’s business development initiatives for expansion to surrounding states.

“Dan is a seasoned mergers and acquistions professional and will be counted on to help us accelerate our growth strategy by executing on key acquisitions in Georgia, North Carolina, South Carolina and Tennessee,” said Troy Yarbrough, chief executive officer of Agape Care. “As we look forward to expanding the Agape Care platform throughout the Southeast Region, Dan’s advanced business acumen will be invaluable to our growth.”

Beuerlein brings over 17 years of experience in multi-state, multi-site healthcare verticals. His diverse skill set, derived from private equity-backed start-ups and large public/private companies, has driven his success as a business development and operations executive in a variety of roles.

Prior to joining Agape Care, Beuerlein served as the chief development officer at BlueSprig Pediatrics. In just two years at BlueSprig, Beuerlein helped the company grow from a start-up with a few clinics in Texas to one of the largest national providers of behavioral therapy for children with autism through a network of 110 clinics in 13 states.

In addition to his time at BlueSprig, Beuerlein also served as the chief development officer and executive vice president of operations at Vivere Health, a leading equity partner and fertility management company. Prior to BlueSprig and Vivere Health, Beuerlein spent time as the chief development officer at Springstone, Inc., and the regional vice president of operations for Symbion Healthcare.

Beuerlein earned a Bachelor of Science in engineering from Tennessee Technological University and an M.B.A. from the Owen Graduate School of Management at Vanderbilt University.

“I’m thrilled to be a part of this incredible team as we work together to increase our acquisition activity,” said Dan Beuerlein, chief development officer of Agape Care. “Coming together as one team, I believe Agape Care will become the leading hospice and palliative care provider in the Southeast Region.”

Note: Hospice Care of South Carolina acquired Agape Hospice in January 2020, and the combined organizations are coming together as one team under a new name – Agape Care. Covering all 46 counties in South Carolina, with 800+ employees and more than 1,400 patients, Agape Care is looking to invigorate their business development pipeline for future expansion.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy